Log In
BCIQ
Print this Print this
 

MB-IL1RA (PRT-1000)

  Manage Alerts
Collapse Summary General Information
Company ProteoThera Inc.
DescriptionMatrix-binding interleukin-1 (IL-1) receptor antagonist
Molecular Target Interleukin-1 (IL-1) receptor
Mechanism of ActionInterleukin-1 (IL-1) receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat acute gout pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today